Dr. Yan Li from #USTC #Hefei #China talks on therapy for #Hepatocellular #Cancer / #HCC. #CXCR1 #nanobody approach to treat HCC & other cancer types. Focused on effects on NK cells. CXCL8 is the ligand. #WIC2025 #SITC2025